Stock

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ANAB and XP

Wednesday, April 8, 2020 - 3:50am

CEDARHURST, N.Y., April 07, 2020 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.

Key Points: 
  • CEDARHURST, N.Y., April 07, 2020 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.
  • Investors Affected: Shares issued in connection with the December 2019 initial public stock offering.
  • Shareholders who purchased shares in these companies during the dates listed are encouraged to contact us via the case links above, by calling toll-free at 1-833-835-1495 or by email (dk@kclasslaw.com).
  • Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

T. Rowe Price Group To Hold 2020 Annual Meeting In Virtual Format Only

Tuesday, April 7, 2020 - 10:09pm

BALTIMORE, April 7, 2020 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced today that itwill hold its Annual Meeting of Stockholders on Tuesday, May 12, 2020 in a virtual format only and is changing the time to 2:00 p.m.

Key Points: 
  • BALTIMORE, April 7, 2020 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced today that itwill hold its Annual Meeting of Stockholders on Tuesday, May 12, 2020 in a virtual format only and is changing the time to 2:00 p.m.
  • As described in the proxy materials for the Annual Meeting previously distributed, stockholders are entitled to participate in the Annual Meeting if they were stockholders as of the close of business on March 11, 2020, the record date, or hold a legal proxy for the meeting provided by their bank, broker, or nominee.
  • Stockholders may ask questions and vote during the Annual Meeting by following the instructions available on the meeting website.
  • Founded in 1937, Baltimore-based T. Rowe Price Group, Inc. ( troweprice.com ), is a global investment management organization with $1.15 trillion in assets under management as of February 29, 2020.

Aimco Announces Dates for First Quarter 2020 Earnings Release and Conference Call

Tuesday, April 7, 2020 - 11:49pm

Aimco is a real estate investment trust that is focused on the ownership and management of quality apartment communities located in the largest markets in the United States.

Key Points: 
  • Aimco is a real estate investment trust that is focused on the ownership and management of quality apartment communities located in the largest markets in the United States.
  • Aimco is one of the country's largest owners and operators of apartments, with 124 communities in 17 states and the District of Columbia.
  • Aimco common shares are traded on the New York Stock Exchange under the ticker symbol AIV, and are included in the S&P 500.
  • For more information about Aimco, please visit our website at www.aimco.com .

SHAREHOLDER ALERT: WeissLaw LLP Reminds QUMU, FSCT, LM, and TERP Shareholders About Its Ongoing Investigations

Tuesday, April 7, 2020 - 9:39pm

Under the terms of the acquisition agreement, FSCT shareholders will receive $33.00 in cash for each share of FSCT common stock that they own.

Key Points: 
  • Under the terms of the acquisition agreement, FSCT shareholders will receive $33.00 in cash for each share of FSCT common stock that they own.
  • Under the terms of the acquisition agreement, LM shareholders will receive $50.00 per share in cash for each LM share that they own.
  • BEP and its affiliates already control 62% of TERP shares and are attempting to acquire the remaining 38% of TERP shares they do not currently control.
  • If you own TERP shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/terraform-power-inc-investigation/

Zentalis Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Tuesday, April 7, 2020 - 9:05pm

All of the shares of common stock in the offering were sold by Zentalis.

Key Points: 
  • All of the shares of common stock in the offering were sold by Zentalis.
  • The Companys common stock began trading on the Nasdaq Global Market on April 3, 2020 under the ticker symbol ZNTL.
  • Morgan Stanley, Jefferies, SVB Leerink and Guggenheim Securities acted as joint book-running managers for the offering.
  • Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers.

Thinking about buying stock in American Airlines, Advanced Micro Devices, Dollar General, General Motors, or Nio?

Tuesday, April 7, 2020 - 2:31pm

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology.

Key Points: 
  • InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology.
  • Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.
  • Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
  • View original content to download multimedia: http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-american-airlines-advanced-micro-devices-dollar-general-general-motors-or-nio-301036698.html

Tri-Continental Corporation Announces Postponement of 90th Annual Meeting of Stockholders

Tuesday, April 7, 2020 - 3:30pm

The Corporation now seeks to hold the Meeting at 707 Second Avenue South, Minneapolis, Minnesota 55474, on June 15, 2020 at 8:00 a.m. local time.

Key Points: 
  • The Corporation now seeks to hold the Meeting at 707 Second Avenue South, Minneapolis, Minnesota 55474, on June 15, 2020 at 8:00 a.m. local time.
  • As described in the proxy materials for the Meeting previously distributed, you are entitled to participate in the Meeting if you were a stockholder as of the close of business on March 3, 2020, the record date.
  • You will need proof of record ownership of the Corporations stock to enter the Meeting or, if your shares are held in street name, a proxy from the record holder.
  • A prospectus containing information about the Corporation (including its investment objectives, risks, charges, expenses, and other information about the Corporation) may be obtained by contacting your financial advisor or visiting columbiathreadneedleus.com.

AT&T to Hold Annual Meeting of Stockholders via Webcast

Tuesday, April 7, 2020 - 3:05pm

In light of the COVID-19 pandemic, AT&T Inc. * ( NYSE:T ) will hold its 2020 Annual Meeting of Stockholders via webcast rather than an in-person meeting.

Key Points: 
  • In light of the COVID-19 pandemic, AT&T Inc. * ( NYSE:T ) will hold its 2020 Annual Meeting of Stockholders via webcast rather than an in-person meeting.
  • In advance of the webcast, stockholders of record and AT&T 401(k) plan participants holding shares as of February 26, 2020, may submit questions to AT&Ts leadership.
  • Stockholders of record as of February 26, 2020, with a control number, will be able to vote during the meeting.
  • Stockholders who hold their shares through a brokerage firm, bank or other entity will continue to provide their voting instructions to these firms.

GOSS INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies Gossamer Bio, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

Tuesday, April 7, 2020 - 3:00pm

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/goss .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/goss .
  • Gossamers most advanced product is its GB001 drug, a DP2 antagonist, in development to treat asthma.
  • In February 2019, Gossamer conducted its initial public offering (IPO), issuing approximately 19.8 million shares of common stock priced at $19.00 per share.
  • or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.

Q BioMed Enters into a Financial Restructuring of Approximately $7,800,000 Consisting of $4,000,000 New Cash and a Minimum of $3,800,000 of Debt Conversion

Tuesday, April 7, 2020 - 1:45pm

Under the agreement, on closing, YA will have converted a minimum of $3,800,000 into common stock and preferred stock and may convert an additional $500,000 which would be the total debt held by them.

Key Points: 
  • Under the agreement, on closing, YA will have converted a minimum of $3,800,000 into common stock and preferred stock and may convert an additional $500,000 which would be the total debt held by them.
  • As part of the agreement, YA will fund an additional $4,000,000 in new capital over the next 2 weeks.
  • This restructuring of the debt and new capital transforms the Company's balance sheet creating significant positive shareholder equity, a requirement for a Nasdaq listing.
  • A current report on Form 8-K detailing the funding translation will be filed with the SEC today.